AGM - [ In - Licensing ], Emerging Markets

Role & Responsibility

Propose & execute strategies to expand our portfolio for generics / specialities via In-Licensing in Emerging Markets- markets (ANZ, Brazil, Mexico, South Africa, Malyasia, Thailand….)

Lead end to end discussion to

identify and categories partners for in licensing

analyze market opportunities assessing their value through comprehensive business cases

negotiate in licensing, distribution, technology transfer or collaboration agreements

schedule regular TC / VC and face to face meetings with licensors worldwide s

generate market intelligence gathering products, sources, development status and market formation

Business case finalization

keep updated track record of licensing projects and payment milestones

define the quickest path towards launch bearing in mind the intellectual property scenario and regulatory procedures feasible

coordinate all activities required after the signature of the contract till launch of the product

Participate in quarterly meetings with the Portfolio department to revise priorities for molecules to in license / acquire or develop, updating the wish list

Prepare every month an update of the licensing activity for HOD.

Present the projects to license along with the corresponding business cases to our Senior Management every month, in order to seek for approval.

Relevant Functional / Technical Skills or Industry Experience

Regulated markets BD experience, Emerging Markets ( Australia , Africa , SEA , etc..) experience preferred

Effective communication and reporting

Experience of leading and coordinating a department’s team

Experience of working across multiple time zone and in global business cultures

Experience in negotiation & deal closure

Good understanding of the way the key pharma industry’s drivers are influencing the launch of products : intellectual property, regulatory, price evolution, retail and hospital channel

Know the relevant players to deal with in the market

Good understanding on regulated and advance market regulatory guidelines and market intel